Latest On Cabaletta Bio, Inc (CABA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-18 16:00 EST | News | Cabaletta Bio up 1%, prices $87M offering | N/A |  |
| 2023-05-18 02:29 EST | News | Cabaletta Bio commences underwritten public offering of shares | N/A | |
| 2023-05-16 23:33 EST | News | Cabaletta Bio jumps 16% as FDA clears trial for myositis candidate | N/A | |
| 2023-05-11 15:27 EST | News | Cabaletta Bio GAAP EPS of -$0.45 beats by $0.02 | N/A | |
| 2023-05-01 18:20 EST | News | Cabaletta's potential lupus drug CABA-201 gets FDA fast track tag | N/A | |
| 2023-04-28 03:16 EST | News | Cabaletta Bio: Speculative Biotech With Opportunity | N/A | |
| 2023-03-31 16:02 EST | News | Cabaletta CAR T cell therapy for lupus gets FDA nod to enter trial | N/A | |
| 2023-03-31 16:02 EST | News | 4 stocks to watch on Friday: Amazon, Kraft Heinz, and more | N/A | |
| 2023-03-16 13:19 EST | News | Cabaletta Bio GAAP EPS of -$0.52 misses by $0.08 | N/A | |
| 2023-01-27 17:59 EST | News | Cabaletta rises as Morgan Stanley upgrades citing new CAR-T asset | N/A | |
| 2023-01-25 12:46 EST | News | Cabaletta: Adding To Position For 36% Return Potential After CABA-201 Rally (Technical Analysis) | N/A | |
| 2022-12-08 20:30 EST | News | Cabaletta Bio dips on announcing $35M offering | N/A | |
| 2022-11-10 11:40 EST | News | Cabaletta Bio GAAP EPS of -$0.39 beats by $0.09 | N/A | |
| 2022-08-30 16:03 EST | News | Cabaletta downgraded at Morgan Stanley on upcoming data for lead asset | N/A | |
| 2022-08-11 21:46 EST | News | Cabaletta Bio GAAP EPS of -$0.45 beats by $0.05 | N/A | |
| 2022-05-18 20:14 EST | News | Cabaletta Bio updates Phase 1 interim data for lead asset | N/A | |
| 2022-05-12 11:04 EST | News | Cabaletta Bio GAAP EPS of -$0.45 | N/A | |
| 2022-03-18 09:46 EST | News | Cabaletta Bio GAAP EPS of -$0.49 beats by $0.11 | N/A | |
| 2021-12-14 08:41 EST | News | Cabaletta Bio tanks 34% on cell therapy data in early-stage study for pemphigus vulgaris | N/A | |
| 2021-11-01 14:01 EST | News | Cabaletta Bio EPS beats by $0.05 | N/A | |
| 2021-11-01 14:01 EST | News | Cabaletta rises as skin diseases drug shown to be safe in early data of phase 1 trial | N/A | |
| 2021-08-19 00:00 EST | News | Cabaletta Bio reports results from DesCAARTes trial in patients with pemphigus vulgaris | N/A | |
| 2021-08-05 20:25 EST | News | Cabaletta Bio EPS beats by $0.03 | N/A | |
| 2021-03-18 15:25 EST | Analyst Rating | The Analyst Target Price has increased from $20.33 to $22.25. | Buy | |
| 2021-03-18 07:46 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-17 17:01 EST | News | Cabaletta Bio EPS misses by $0.04 | N/A | |
| 2021-03-17 15:39 EST | Earnings Estimate | An EPS average of -$0.46 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-17 15:39 EST | Earnings Estimate | An EPS average of -$2.18 is estimated for the 2022 year. | Sell | |
| 2021-01-20 12:58 EST | News | Cabaletta: DSG3-CAART's 1H 2021 Data Release Can Substantiate This Young Biotech | N/A | |
| 2021-01-11 10:22 EST | Analyst Rating | The Analyst Target Price has increased from $20 to $20.33. | Buy | |
| 2021-01-09 03:37 EST | News | Chardan Capital initiates Cabaletta Bio with Buy rating | N/A | |
| 2020-12-10 06:47 EST | News | Dosing underway in Cabaletta Bio's DSG3-CAART study in a rare skin blistering disorder | N/A | |
| 2020-12-04 06:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-27 00:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-24 15:51 EST | Analyst Rating | The Analyst Target Price has decreased from $21.67 to $20. | Neutral | |
| 2020-11-17 07:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-14 23:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-12 07:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-11 09:52 EST | News | Cabaletta Bio EPS beats by $0.08 | N/A | |
| 2020-11-11 09:52 EST | News | Cabaletta Bio +5% on Q3 results, pipeline update | N/A | |
| 2020-11-11 06:54 EST | Earnings Estimate | An EPS average of -$0.44 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-10-15 08:02 EST | News | Cabaletta Bio (CABA) Investor Presentation - Slideshow | N/A | |
| 2020-10-14 11:22 EST | Analyst Rating | The Analyst Target Price has decreased from $22.5 to $21.67. | Neutral | |
| 2020-10-08 21:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-04 15:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 09:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-10 03:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-07 23:40 EST | Financials | Company financials have been released. | Neutral | |
About Cabaletta Bio, Inc (CABA):
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also include MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. Cabaletta Bio, Inc. has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was founded in 2017 and is headquartered in Philadelphia, Pennsylvania.
General
- Name Cabaletta Bio, Inc
- Symbol CABA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 31
- Fiscal Year EndDecember
- IPO Date2019-10-25
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Web URLhttp://www.cabalettabio.com
View More
Valuation
- Price/Book (Most Recent Quarter) 2.23
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.13
- Next Year EPS Estimate -$2.45
- Next Quarter EPS Estimate -$0.42
- Return on Assets -17%
- Return on Equity -27%
- Earnings Per Share -$0.94
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 276.24 million
- Analyst Target Price $22.25
View More
Share Statistics
- Shares Outstanding 24.06 million
- Shares Float 7.91 million
- % Held by Insiders 523%
- % Held by Institutions 67.4%
- Shares Short 1.63 million
- Shares Short Prior Month 1.61 million
- Short Ratio 15.52
- Short % of Float 8%
- Short % of Shares Outstanding 7%
View More
Technicals
- 52 Week High $16.38
- 52 Week Low $6.07
- 50 Day Moving Average 11.96
- 200 Day Moving Average 12.4
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Cabaletta Bio, Inc (CABA) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Cabaletta Bio, Inc (CABA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-16 | $N/A | -$0.40 | -$0.36 | -11.11% |
| 2020-09-30 | 2020-11-10 | $N/A | -$0.36 | -$0.44 | 18.18% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.35 | -$0.39 | 10.26% |
| 2020-03-31 | 2020-05-12 | $N/A | -$0.33 | -$0.23 | -43.48% |
| 2019-12-31 | 2020-03-30 | $N/A | -$0.33 | -$0.47 | 29.79% |
| 2019-09-30 | 2019-12-05 | $N/A | -$1.21 | -$2.26 | 46.46% |
Cabaletta Bio, Inc (CABA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Cabaletta Bio, Inc (CABA) Chart:
Cabaletta Bio, Inc (CABA) News:
Below you will find a list of latest news for Cabaletta Bio, Inc (CABA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Cabaletta Bio, Inc (CABA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 21 | CALL | 0 | 88 | 815.79 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 12.1 | CALL | 0 | 5 | 575.18 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 12 | CALL | 0 | 5 | 332.05 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 1.15 | CALL | 0 | 36 | 198.7 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 1.2 | CALL | 11 | 109 | 116.24 | TRUE | -0.15 | -0.11 |
| 2024-05-17 | 15 | 0.4 | CALL | 32 | 449 | 115.78 | FALSE | -0.2 | -0.33 |
| 2024-05-17 | 17.5 | 0.17 | CALL | 3 | 1155 | 128.48 | FALSE | -0.02 | -0.11 |
| 2024-05-17 | 20 | 0.1 | CALL | 0 | 148 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 22.5 | 0.05 | CALL | 0 | 129 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 25 | 0.05 | CALL | 0 | 796 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 30 | 0.2 | CALL | 0 | 97 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 35 | 0.2 | CALL | 0 | 49 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.15 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0.55 | PUT | 0 | 57 | 187.43 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 1.86 | PUT | 0 | 3172 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 3.85 | PUT | 0 | 2187 | 181.06 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 6.59 | PUT | 0 | 59 | 238.88 | TRUE | 0 | 0 |
| 2024-05-17 | 20 | 10.2 | PUT | 0 | 60 | 265.32 | TRUE | 0 | 0 |
| 2024-05-17 | 22.5 | 5 | PUT | 0 | 42 | 301.17 | TRUE | 0 | 0 |
| 2024-05-17 | 25 | 15.11 | PUT | 0 | 0 | 232.91 | TRUE | 0 | 0 |
| 2024-05-17 | 30 | 11.1 | PUT | 0 | 0 | 288.36 | TRUE | 0 | 0 |
| 2024-05-17 | 35 | 21.4 | PUT | 0 | 2 | 365.45 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 447.93 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 252.7 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 189.96 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0 | CALL | 0 | 0 | 164.28 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 1.15 | CALL | 0 | 5 | 103.35 | TRUE | 0 | 0 |
| 2024-06-21 | 15 | 1.35 | CALL | 4 | 18 | 116.49 | FALSE | -0.1 | -0.07 |
| 2024-06-21 | 17.5 | 0.9 | CALL | 0 | 26 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 20 | 0.62 | CALL | 1 | 3 | 126.31 | FALSE | 0.12 | 0.24 |
| 2024-06-21 | 22.5 | 0 | CALL | 0 | 0 | 122.03 | FALSE | 0 | 0 |
| 2024-06-21 | 25 | 0.21 | CALL | 0 | 90 | 138.97 | FALSE | 0 | 0 |
| 2024-06-21 | 30 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0.7 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0.55 | PUT | 0 | 14 | 187.77 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 1.65 | PUT | 0 | 21 | 134.22 | FALSE | 0 | 0 |
| 2024-06-21 | 12.5 | 1.9 | PUT | 0 | 3 | 127.66 | FALSE | 0 | 0 |
| 2024-06-21 | 15 | 5.2 | PUT | 0 | 2 | 110.66 | TRUE | 0 | 0 |
| 2024-06-21 | 17.5 | 0 | PUT | 0 | 0 | 131.15 | TRUE | 0 | 0 |
| 2024-06-21 | 20 | 0 | PUT | 0 | 0 | 167.95 | TRUE | 0 | 0 |
| 2024-06-21 | 22.5 | 0 | PUT | 0 | 0 | 140.45 | TRUE | 0 | 0 |
| 2024-06-21 | 25 | 0 | PUT | 0 | 0 | 168.49 | TRUE | 0 | 0 |
| 2024-06-21 | 30 | 0 | PUT | 0 | 0 | 210.85 | TRUE | 0 | 0 |
| 2024-07-19 | 2.5 | 0 | CALL | 0 | 0 | 333.26 | TRUE | 0 | 0 |
| 2024-07-19 | 5 | 0 | CALL | 0 | 0 | 247.71 | TRUE | 0 | 0 |
| 2024-07-19 | 7.5 | 0 | CALL | 0 | 0 | 153.88 | TRUE | 0 | 0 |
| 2024-07-19 | 10 | 4.3 | CALL | 36 | 20 | 135.35 | TRUE | 4.3 | 0 |
| 2024-07-19 | 12.5 | 2.75 | CALL | 100 | 757 | 116.24 | TRUE | 0.6 | 0.28 |
| 2024-07-19 | 15 | 2 | CALL | 5 | 23 | 120.47 | FALSE | 0.65 | 0.48 |
| 2024-07-19 | 17.5 | 1.35 | CALL | 46 | 21 | 117.71 | FALSE | 1.35 | 0 |
| 2024-07-19 | 20 | 0.85 | CALL | 45 | 39 | 112.76 | FALSE | 0.85 | 0 |
| 2024-07-19 | 22.5 | 0.4 | CALL | 0 | 23 | 130.68 | FALSE | 0 | 0 |
| 2024-07-19 | 25 | 0.47 | CALL | 0 | 1024 | 122.79 | FALSE | 0 | 0 |
| 2024-07-19 | 30 | 1.5 | CALL | 0 | 401 | 155.84 | FALSE | 0 | 0 |
| 2024-07-19 | 35 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 2.5 | 0.05 | PUT | 0 | 49 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-07-19 | 7.5 | 0 | PUT | 0 | 0 | 173.91 | FALSE | 0 | 0 |
| 2024-07-19 | 10 | 2.1 | PUT | 0 | 4 | 144.09 | FALSE | 0 | 0 |
| 2024-07-19 | 12.5 | 2.85 | PUT | 0 | 36 | 137.04 | FALSE | 0 | 0 |
| 2024-07-19 | 15 | 5.15 | PUT | 0 | 3 | 122.62 | TRUE | 0 | 0 |
| 2024-07-19 | 17.5 | 7.15 | PUT | 0 | 10 | 120.61 | TRUE | 0 | 0 |
| 2024-07-19 | 20 | 0 | PUT | 0 | 0 | 131.55 | TRUE | 0 | 0 |
| 2024-07-19 | 22.5 | 6.1 | PUT | 0 | 10 | 92.92 | TRUE | 0 | 0 |
| 2024-07-19 | 25 | 8.38 | PUT | 0 | 3 | 149.2 | TRUE | 0 | 0 |
| 2024-07-19 | 30 | 12 | PUT | 0 | 1 | 163.32 | TRUE | 0 | 0 |
| 2024-07-19 | 35 | 0 | PUT | 0 | 0 | 227.52 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | CALL | 0 | 0 | 294.01 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 0 | CALL | 0 | 0 | 163.68 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | CALL | 0 | 0 | 133.83 | TRUE | 0 | 0 |
| 2024-08-16 | 10 | 14.14 | CALL | 0 | 1 | 108.9 | TRUE | 0 | 0 |
| 2024-08-16 | 12.5 | 2.8 | CALL | 0 | 500 | 77.48 | TRUE | 0 | 0 |
| 2024-08-16 | 15 | 0 | CALL | 0 | 0 | 112.72 | FALSE | 0 | 0 |
| 2024-08-16 | 17.5 | 1.6 | CALL | 5 | 2 | 109.88 | FALSE | 1.6 | 0 |
| 2024-08-16 | 20 | 2.2 | CALL | 0 | 34 | 121.1 | FALSE | 0 | 0 |
| 2024-08-16 | 22.5 | 2.33 | CALL | 0 | 56 | 127.75 | FALSE | 0 | 0 |
| 2024-08-16 | 25 | 0.75 | CALL | 0 | 66 | 120.21 | FALSE | 0 | 0 |
| 2024-08-16 | 30 | 0.25 | CALL | 0 | 13 | 130.4 | FALSE | 0 | 0 |
| 2024-08-16 | 35 | 0.2 | CALL | 0 | 107 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.1 | PUT | 0 | 12 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0 | PUT | 0 | 0 | 163.78 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 1.04 | PUT | 0 | 18 | 131.27 | FALSE | 0 | 0 |
| 2024-08-16 | 10 | 0 | PUT | 0 | 0 | 115.9 | FALSE | 0 | 0 |
| 2024-08-16 | 12.5 | 1.78 | PUT | 0 | 2 | 105.62 | FALSE | 0 | 0 |
| 2024-08-16 | 15 | 3.5 | PUT | 0 | 35 | 111.84 | TRUE | 0 | 0 |
| 2024-08-16 | 17.5 | 6.7 | PUT | 0 | 5003 | 118.32 | TRUE | 0 | 0 |
| 2024-08-16 | 20 | 8 | PUT | 0 | 61 | 124.7 | TRUE | 0 | 0 |
| 2024-08-16 | 22.5 | 0 | PUT | 0 | 0 | 86.12 | TRUE | 0 | 0 |
| 2024-08-16 | 25 | 0 | PUT | 0 | 0 | 137.11 | TRUE | 0 | 0 |
| 2024-08-16 | 30 | 12.3 | PUT | 0 | 10 | 129.16 | TRUE | 0 | 0 |
| 2024-08-16 | 35 | 16 | PUT | 0 | 4 | 156.47 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | CALL | 0 | 0 | 189.53 | TRUE | 0 | 0 |
| 2024-11-15 | 5 | 0 | CALL | 0 | 0 | 158.75 | TRUE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | CALL | 0 | 0 | 121.72 | TRUE | 0 | 0 |
| 2024-11-15 | 10 | 0 | CALL | 0 | 0 | 92.16 | TRUE | 0 | 0 |
| 2024-11-15 | 12.5 | 0 | CALL | 0 | 0 | 97.17 | TRUE | 0 | 0 |
| 2024-11-15 | 15 | 3.9 | CALL | 0 | 1 | 99.39 | FALSE | 0 | 0 |
| 2024-11-15 | 17.5 | 2.94 | CALL | 0 | 14 | 101.02 | FALSE | 0 | 0 |
| 2024-11-15 | 20 | 2.52 | CALL | 1 | 39 | 117.2 | FALSE | 2.52 | 0 |
| 2024-11-15 | 22.5 | 3.3 | CALL | 0 | 13 | 103.47 | FALSE | 0 | 0 |
| 2024-11-15 | 25 | 4.66 | CALL | 0 | 2 | 106.23 | FALSE | 0 | 0 |
| 2024-11-15 | 30 | 0 | CALL | 0 | 0 | 117.08 | FALSE | 0 | 0 |
| 2024-11-15 | 35 | 0.35 | CALL | 0 | 1 | 125.64 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 7.5 | 1.58 | PUT | 0 | 5 | 125.46 | FALSE | 0 | 0 |
| 2024-11-15 | 10 | 3.53 | PUT | 0 | 0 | 106.82 | FALSE | 0 | 0 |
| 2024-11-15 | 12.5 | 4 | PUT | 0 | 45 | 94.84 | FALSE | 0 | 0 |
| 2024-11-15 | 15 | 0 | PUT | 0 | 0 | 95.73 | TRUE | 0 | 0 |
| 2024-11-15 | 17.5 | 0 | PUT | 0 | 0 | 103.92 | TRUE | 0 | 0 |
| 2024-11-15 | 20 | 0 | PUT | 0 | 0 | 105.44 | TRUE | 0 | 0 |
| 2024-11-15 | 22.5 | 0 | PUT | 0 | 0 | 103.9 | TRUE | 0 | 0 |
| 2024-11-15 | 25 | 0 | PUT | 0 | 0 | 102.54 | TRUE | 0 | 0 |
| 2024-11-15 | 30 | 0 | PUT | 0 | 0 | 114.95 | TRUE | 0 | 0 |
| 2024-11-15 | 35 | 0 | PUT | 0 | 0 | 122.23 | TRUE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | CALL | 0 | 0 | 157.69 | TRUE | 0 | 0 |
| 2024-12-20 | 5 | 0 | CALL | 0 | 0 | 168.34 | TRUE | 0 | 0 |
| 2024-12-20 | 7.5 | 0 | CALL | 0 | 0 | 115.58 | TRUE | 0 | 0 |
| 2024-12-20 | 10 | 6 | CALL | 0 | 10 | 113.48 | TRUE | 0 | 0 |
| 2024-12-20 | 12.5 | 3.2 | CALL | 0 | 87 | 108.89 | TRUE | 0 | 0 |
| 2024-12-20 | 15 | 2.2 | CALL | 0 | 26 | 112.2 | FALSE | 0 | 0 |
| 2024-12-20 | 17.5 | 1.34 | CALL | 0 | 15 | 103.82 | FALSE | 0 | 0 |
| 2024-12-20 | 20 | 2.2 | CALL | 10 | 65 | 99.46 | FALSE | 2.2 | 0 |
| 2024-12-20 | 22.5 | 1.81 | CALL | 0 | 35 | 100.81 | FALSE | 0 | 0 |
| 2024-12-20 | 25 | 2 | CALL | 0 | 79 | 116.07 | FALSE | 0 | 0 |
| 2024-12-20 | 30 | 1.11 | CALL | 0 | 109 | 114.58 | FALSE | 0 | 0 |
| 2024-12-20 | 35 | 0.8 | CALL | 0 | 71 | 109.98 | FALSE | 0 | 0 |
| 2024-12-20 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 5 | 0 | PUT | 0 | 0 | 155.89 | FALSE | 0 | 0 |
| 2024-12-20 | 7.5 | 1.73 | PUT | 0 | 13 | 109.64 | FALSE | 0 | 0 |
| 2024-12-20 | 10 | 2.85 | PUT | 2 | 2 | 122.02 | FALSE | 2.85 | 0 |
| 2024-12-20 | 12.5 | 3.69 | PUT | 0 | 73 | 109.53 | FALSE | 0 | 0 |
| 2024-12-20 | 15 | 5.58 | PUT | 0 | 12 | 117.53 | TRUE | 0 | 0 |
| 2024-12-20 | 17.5 | 8 | PUT | 0 | 5 | 112.08 | TRUE | 0 | 0 |
| 2024-12-20 | 20 | 6.6 | PUT | 0 | 10 | 112.59 | TRUE | 0 | 0 |
| 2024-12-20 | 22.5 | 7.3 | PUT | 0 | 5 | 114.52 | TRUE | 0 | 0 |
| 2024-12-20 | 25 | 12.7 | PUT | 0 | 3 | 115.98 | TRUE | 0 | 0 |
| 2024-12-20 | 30 | 14.5 | PUT | 0 | 2 | 115.73 | TRUE | 0 | 0 |
| 2024-12-20 | 35 | 24 | PUT | 0 | 5 | 132.52 | TRUE | 0 | 0 |
Latest CABA Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:37 PM EST | 1 | $1.08 |
| Jun 13, 2022 7:37 PM EST | 6 | $1.08 |
| Jun 13, 2022 7:51 PM EST | 7 | $1.06 |
| Jun 13, 2022 7:57 PM EST | 7 | $1.06 |
| Jun 13, 2022 7:58 PM EST | 7 | $1.055 |
Cabaletta Bio, Inc (CABA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520159049/0001193125-20-159049-index.htm |
| 2019-10-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319025941/0000899243-19-025941-index.htm |
| 2019-10-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319025942/0000899243-19-025942-index.htm |
| 2019-10-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319025943/0000899243-19-025943-index.htm |
| 2019-10-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319025946/0000899243-19-025946-index.htm |
| 2019-10-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319025947/0000899243-19-025947-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319026016/0000899243-19-026016-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319026017/0000899243-19-026017-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319026018/0000899243-19-026018-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319026020/0000899243-19-026020-index.htm |
| 2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319026345/0000899243-19-026345-index.htm |
| 2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924319026346/0000899243-19-026346-index.htm |
| 2020-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924320004509/0000899243-20-004509-index.htm |
| 2020-02-13 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924320004511/0000899243-20-004511-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924320006864/0000899243-20-006864-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924320006865/0000899243-20-006865-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924320006867/0000899243-20-006867-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000089924320025326/0000899243-20-025326-index.htm |
| 2020-07-21 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759138/000090266420002724/0000902664-20-002724-index.htm |
| 2019-11-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759138/000092963819000988/0000929638-19-000988-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759138/000092963820000331/0000929638-20-000331-index.htm |
| 2019-10-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000110465919056233/0001104659-19-056233-index.htm |
| 2019-10-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000110465919057348/0001104659-19-057348-index.htm |
| 2019-10-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000110465919058504/0001104659-19-058504-index.htm |
| 2019-11-12 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1759138/000110465919061822/0001104659-19-061822-index.htm |
| 2019-10-24 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1759138/000119312519273939/0001193125-19-273939-index.htm |
| 2019-10-25 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1759138/000119312519274807/0001193125-19-274807-index.htm |
| 2019-10-29 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1759138/000119312519277804/0001193125-19-277804-index.htm |
| 2019-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312519278927/0001193125-19-278927-index.htm |
| 2019-11-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759138/000119312519287367/0001193125-19-287367-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520005110/0001193125-20-005110-index.htm |
| 2020-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520017724/0001193125-20-017724-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759138/000119312520038349/0001193125-20-038349-index.htm |
| 2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520042689/0001193125-20-042689-index.htm |
| 2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520090013/0001193125-20-090013-index.htm |
| 2020-03-30 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1759138/000119312520091086/0001193125-20-091086-index.htm |
| 2020-04-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1759138/000119312520115863/0001193125-20-115863-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520134391/0001193125-20-134391-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520139782/0001193125-20-139782-index.htm |
| 2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520153792/0001193125-20-153792-index.htm |
| 2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520159049/0001193125-20-159049-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1759138/000119312520211336/0001193125-20-211336-index.htm |
| 2019-10-30 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759138/000119380519001374/0001193805-19-001374-index.htm |
| 2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1759138/000119380519001376/0001193805-19-001376-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1759138/000119380520000185/0001193805-20-000185-index.htm |
| 2019-12-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1759138/000156459019045375/0001564590-19-045375-index.htm |
| 2020-03-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1759138/000156459020013929/0001564590-20-013929-index.htm |
| 2020-05-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1759138/000156459020024508/0001564590-20-024508-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1759138/000156459020037278/0001564590-20-037278-index.htm |
| 2019-10-24 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1759138/999999999519002384/9999999995-19-002384-index.htm |
Cabaletta Bio, Inc (CABA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cabaletta Bio, Inc (CABA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 523%Institutional Ownership: 6740%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-10-29 | 5AM Ventures V, L.P. | 10% Share Holder | Buy | 454,545.00 | 11.00 | 4,999,995.00 | 454,545.00 | https://www.sec.gov/Archives/edgar/data/1759138/000110465919058504/0001104659-19-058504-index.htm |
| 2019-10-29 | James E Flynn | 10% Share Holder | Buy | 700,000.00 | 11.00 | 7,700,000.00 | 700,000.00 | https://www.sec.gov/Archives/edgar/data/1759138/000119380519001376/0001193805-19-001376-index.htm |